NTLA
Intellia Therapeutics Inc.
Company Overview
| Mkt Cap | $1.50B | Price | $12.62 |
| Volume | 14.23M | Change | +2.89% |
| P/E Ratio | -2.9 | Open | $12.55 |
| Revenue | $57.9M | Prev Close | $12.27 |
| Net Income | $-519.0M | 52W Range | $5.90 - $28.25 |
| Div Yield | N/A | Target | $33.46 |
| Overall | 55 | Value | 60 |
| Quality | -- | Technical | 50 |
No chart data available
Stock Overview
Updated DailyIntellia Therapeutics Inc. (NTLA) is a leading Healthcare company in the Biotechnology industry, currently trading at $12.62 with a market capitalization of $1.50 billion. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows NTLA with a volume of 14.23 million shares. The stock opened up 2.32% from yesterday's close of $12.27. Current analyst estimates project earnings of $-4.14 per share for this year, with next year targeting $-4.1.
NTLA demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for NTLA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 165.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $12.62 | +2.9% | 14.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW